Inhibition of Granule Cell Dispersion and Seizure Development by Astrocyte Elevated Gene-1 in a Mouse Model of Temporal Lobe Epilepsy

Eunju Leem,Sehwan Kim,Chanchal Sharma,Youngpyo Nam,Tae Yeon Kim,Minsang Shin,Seok-Geun Lee,Jaekwang Kim,Sang Ryong Kim
DOI: https://doi.org/10.3390/biom14030380
IF: 6.064
2024-03-21
Biomolecules
Abstract:Although granule cell dispersion (GCD) in the hippocampus is known to be an important feature associated with epileptic seizures in temporal lobe epilepsy (TLE), the endogenous molecules that regulate GCD are largely unknown. In the present study, we have examined whether there is any change in AEG-1 expression in the hippocampus of a kainic acid (KA)-induced mouse model of TLE. In addition, we have investigated whether the modulation of astrocyte elevated gene-1 (AEG-1) expression in the dentate gyrus (DG) by intracranial injection of adeno-associated virus 1 (AAV1) influences pathological phenotypes such as GCD formation and seizure susceptibility in a KA-treated mouse. We have identified that the protein expression of AEG-1 is upregulated in the DG of a KA-induced mouse model of TLE. We further demonstrated that AEG-1 upregulation by AAV1 delivery in the DG-induced anticonvulsant activities such as the delay of seizure onset and inhibition of spontaneous recurrent seizures (SRS) through GCD suppression in the mouse model of TLE, while the inhibition of AEG-1 expression increased susceptibility to seizures. The present observations suggest that AEG-1 is a potent regulator of GCD formation and seizure development associated with TLE, and the significant induction of AEG-1 in the DG may have therapeutic potential against epilepsy.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the role of astrocyte elevated gene - 1 (AEG - 1) in temporal lobe epilepsy (TLE) and its underlying mechanisms. Specifically, the researchers focused on the following aspects: 1. **Changes in AEG - 1 expression**: The study first examined whether the expression of AEG - 1 in the hippocampus was affected by the kainic acid (KA) - induced TLE mouse model. Through immunostaining and Western blot analysis, it was found that after KA treatment, the expression of AEG - 1 in the DG region increased significantly, while in CA1, CA3 and other regions of the dentate gyrus, neuronal loss and a decrease in AEG - 1 expression occurred. 2. **The impact of AEG - 1 on epileptic seizures**: The researchers further explored whether the up - regulation or down - regulation of AEG - 1 expression would affect the latency, severity and duration of epileptic seizures in the KA - induced mouse model. The results showed that over - expression of AEG - 1 could significantly delay the onset of epileptic seizures and reduce the severity of seizures; conversely, silencing of AEG - 1 would shorten the latency of epileptic seizures and exacerbate the severity of seizures. 3. **The impact of AEG - 1 on the mTORC1 pathway**: To explore the potential mechanisms by which AEG - 1 affects epileptic seizures, the researchers examined the activation of the mTORC1 pathway. It is known that excessive activation of mTORC1 is one of the key molecular mechanisms in the occurrence of TLE. The experimental results showed that over - expression of AEG - 1 could significantly inhibit the expression of p - 4E - BP1 and p - p70S6K in the DG region after KA treatment. These two proteins are markers of mTORC1 activation. This suggests that AEG - 1 may play its anti - epileptic role by negatively regulating the mTORC1 pathway. In summary, this paper aims to reveal the role of AEG - 1 in TLE and the specific mechanisms by which it affects epileptic seizures by regulating the mTORC1 pathway. These findings provide a new perspective for understanding the pathophysiological processes of TLE and may provide a theoretical basis for the development of new treatment strategies.